Selmic Laura E, Ryan Stewart D, Boston Sarah E, Liptak Julius M, Culp William T N, Sartor Angela J, Prpich Cassandra Y, Withrow Stephen J
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.
J Am Vet Med Assoc. 2014 May 1;244(9):1053-9. doi: 10.2460/javma.244.9.1053.
To determine the signalment, tibial plateau leveling osteotomy (TPLO) plate type, clinical staging information, treatment, and oncological outcome in dogs that developed osteosarcoma at the proximal aspect of the tibia following TPLO and to calculate the interval between TPLO and osteosarcoma diagnosis.
Multi-institutional retrospective case series.
29 dogs.
Medical records from 8 participating institutions were searched for dogs that developed osteosarcoma (confirmed through cytologic or histologic evaluation) at previous TPLO sites. Signalment, TPLO details, staging tests, treatment data, and outcome information were recorded. Descriptive statistics were calculated, and disease-free intervals and survival times were evaluated by means of Kaplan-Meier analysis.
29 dogs met the inclusion criteria. The mean age was 9.2 years and mean weight was 45.1 kg (99.2 lb) at the time of osteosarcoma diagnosis. Most dogs had swelling over the proximal aspect of the tibia (17/21) and lameness of the affected limb (28/29). The mean interval between TPLO and osteosarcoma diagnosis was 5.3 years. One type of cast stainless steel TPLO plate was used in most (18) dogs; the remaining dogs had received plates of wrought stainless steel (n = 4) or unrecorded type (7). Twenty-three of 29 dogs underwent treatment for osteosarcoma. Median survival time for 10 dogs that underwent amputation of the affected limb and received ≥ 1 chemotherapeutic treatment was 313 days.
Results supported that osteosarcoma should be a differential diagnosis for dogs with a history of TPLO that later develop lameness and swelling at the previous surgical site. Oncological outcome following amputation and chemotherapy appeared to be similar to outcomes previously reported for dogs with appendicular osteosarcoma.
确定接受胫骨平台水平截骨术(TPLO)后在胫骨近端发生骨肉瘤的犬只的特征、TPLO钢板类型、临床分期信息、治疗方法及肿瘤学结局,并计算TPLO与骨肉瘤诊断之间的间隔时间。
多机构回顾性病例系列研究。
29只犬。
检索8家参与机构的医疗记录,查找在先前TPLO部位发生骨肉瘤(经细胞学或组织学评估确诊)的犬只。记录其特征、TPLO详细信息、分期检查、治疗数据及结局信息。计算描述性统计量,并通过Kaplan-Meier分析评估无病间期和生存时间。
29只犬符合纳入标准。骨肉瘤诊断时的平均年龄为9.2岁,平均体重为45.1千克(99.2磅)。大多数犬在胫骨近端有肿胀(17/21),患肢跛行(28/29)。TPLO与骨肉瘤诊断之间的平均间隔时间为5.3年。大多数(18只)犬使用了一种铸造不锈钢TPLO钢板;其余犬使用的是锻造不锈钢钢板(n = 4)或未记录类型的钢板(7只)。29只犬中有23只接受了骨肉瘤治疗。10只接受患肢截肢并接受≥1次化疗的犬的中位生存时间为313天。
结果表明,对于有TPLO病史且后来在先前手术部位出现跛行和肿胀的犬只,骨肉瘤应作为鉴别诊断。截肢和化疗后的肿瘤学结局似乎与先前报道的四肢骨肉瘤犬的结局相似。